We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in NGM Biopharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 75 → 0 (-75)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $55.1M → $0 (-$55.1M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 74

Holders
–
Holders Change
-75
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
74
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CG
Column Group
California
-$28.8M
2
BlackRock
BlackRock
New York
-$4.78M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$3.7M
4
SG
StepStone Group
California
-$2.5M
5
EC
Euclidean Capital
New York
-$1.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
51
AQR Capital Management
Connecticut
– -$27K -16,963 Closed
CSS
52
Cubist Systematic Strategies
Connecticut
– -$25.3K -15,910 Closed
State Board of Administration of Florida Retirement System
53
State Board of Administration of Florida Retirement System
Florida
– -$63.9K -15,654 Closed
Wells Fargo
54
Wells Fargo
California
– -$24.5K -15,407 Closed
SG Americas Securities
55
SG Americas Securities
New York
– -$24K -15,074 Closed
Invesco
56
Invesco
Georgia
– -$20.6K -12,936 Closed
VPIM
57
Vanguard Personalized Indexing Management
California
– -$18.5K -11,644 Closed
T. Rowe Price Associates
58
T. Rowe Price Associates
Maryland
– -$18K -10,869 Closed
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
– -$16.3K -10,252 Closed
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
– -$6.97K -4,381 Closed
TRCT
61
Tower Research Capital (TRC)
New York
– -$5.81K -3,654 Closed
AIP
62
Ameritas Investment Partners
Nebraska
– -$4.96K -3,117 Closed
Legal & General Group
63
Legal & General Group
United Kingdom
– -$4.82K -3,029 Closed
AB
64
Amalgamated Bank
New York
– -$2K -1,373 Closed
Royal Bank of Canada
65
Royal Bank of Canada
Ontario, Canada
– -$2K -1,095 Closed
Group One Trading
66
Group One Trading
Illinois
– -$1.67K -1,052 Closed
CAL
67
Capital Advisors Ltd
Ohio
– -$1K -777 Closed
GI
68
GAMMA Investing
California
– -$550 -346 Closed
FFA
69
Farther Finance Advisors
California
– -$150 -96 Closed
Nisa Investment Advisors
70
Nisa Investment Advisors
Missouri
– -$119 -75 Closed
AWM
71
Avior Wealth Management
Nebraska
– -$11 -7 Closed
1 2
3

NGM Hedge Fund Activity: Q2 2024 in Review

0 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in NGM Biopharmaceuticals, Inc. Common Stock (NGM) for Q2 2024, worth a combined $0 — down 100% from $55.1M a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of NGM and 0 opened new positions — a net loss of 74 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Column Group, exiting entirely with an estimated $28.8M sold.

  • 0 institutional investors held NGM Biopharmaceuticals, Inc. Common Stock (NGM) as of Q2 2024, down from 75 in Q1 2024.
  • Funds reported $0 of NGM Biopharmaceuticals, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new NGM Biopharmaceuticals, Inc. Common Stock positions in Q2 2024 and 74 closed out, a net change of -74 holders.
  • The largest NGM Biopharmaceuticals, Inc. Common Stock seller in Q2 2024 was Column Group, an estimated $28.8M sold.

Based on aggregated 13F filings for Q2 2024.